Eyeworld

DEC 2015

EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.

Issue link: https://digital.eyeworld.org/i/611088

Contents of this Issue

Navigation

Page 13 of 98

11 EW NEWS & OPINION Headline byline goes here plus fade December 2015 A one-and-a-half-day inten- sive educational program was created for U.S. resi- dents and fellows in oph- thalmology and surgeons in their first 5 years of practice. The Young Eye Surgeons (YES) Advanced Cataract Training will take place March 5–6, 2016, in Manhattan at the New York Marriott Downtown. Registration will be complimentary for U.S. residents and fellows. Travel stipends will also be provided for the attendees in training who reside outside of the greater New York area. Developed by ASCRS, New York University School of Medicine, and New York Eye and Ear Infirmary of Mount Sinai (NYEE), the program includes didactics, surgical video case presentations, a hands-on wet lab, and roundtable discussion breakout sessions. The program chairs are Eric Donnenfeld, MD, Elizabeth Yeu, MD, Jack Dodick, MD, and Lisa Park, MD. Dr. Yeu described the program as "designed specifically to strengthen the foun- dation and add layers of new skills to the younger surgeon's anterior segment skill set. A broad range of topics will be covered, including a In the journal . . . Trabecular micro bypass stent implantation during small-incision cataract surgery for open-angle glaucoma or ocular hypertension: Long-term results Tobias Neuhann, MD Investigators in this prospective, non-randomized study set out to determine how safe and effective implantation of the iStent trabecular micro bypass stent was in conjunction with cataract surgery. The iStent was implanted here in 42 patients with ocular hypertension or with various types of glaucoma including primary open-angle, pseudoexfoliation and secondary or post-traumatic forms of the condition, with the majority of eyes followed for 3 years. While preoperatively patients had a mean IOP of 24.1 mm Hg, at the 1-year postoperative mark IOP had dropped to 14.8 mm Hg. Likewise, at 24 months this was measured at 14.5 mm Hg and at 36 months at a mean of 14.9 mm Hg. Investigators found that at the 36-month mark, 74% of eyes no longer required medication, while preopera- tively a mean of 1.8 medications had been needed. However, additional glauco- ma surgery after implantation of the stent was required in 5 eyes. Of these, 1 had pseudoexfoliation syndrome and 4 had undergone previous glaucoma surgery. At the 3-year mark, 93% of eyes had 20/40 or better corrected distance acuity, and no intraoperative or postoperative complications often seen with conventional glaucoma surgery occurred. Investigators concluded that implantation of the iStent, done during cataract surgery, was safe and effective in glaucoma or ocular hypertension patients. Surgical, antiseptic, and antibiotic practice in cataract surgery: Results from the European Observatory in 2013 Anders Behndig, Beatrice Cochener-Lamard, José Güell, Laurent Kodjikian, Rita Mencucci, Rudy Nuijts, Uwe Pleyer, Paul Rosen, Jacek Szaflik, Marie-Jose Tassignon How similar is endophthalmitis prophylaxis for cataract surgery among European ophthalmic surgeons? The European Observatory of Cataract Surgery tracked changes in surgical, antiseptic, and antibiotic practices used by 479 European cataract surgeons in a baseline survey. To garner this information, either an Internet-based or telephone questionnaire was used. The survey showed that prophylaxis here varied widely. While there was almost universal adoption of in- tracameral cefuroxime in some countries, in others such usage involved less than half of practices. Most commonly, cefuroxime powder designed for parenteral use was adopted. However, in countries where intracameral usage of cefuroxime was the norm, a preparation specifically registered for intracameral use was more commonly embraced. Investigators here concluded that the baseline results of this ongoing survey indicated that currently there is a lot of variation in endoph- thalmitis prophylaxis among European countries. Optical quality of trifocal and progressive IOLs Alberto Domínguez-Vicent, MSc, Jose Juan Esteve-Taboada, PhD, Antonio J. Del Águila-Carrasco, MSc, Teresa Ferrer-Blasco, PhD, Robert Montés-Micó, PhD In this study, investigators compared how 3 multifocal intraocular lenses stacked up in terms of optical quality. These included the Mini WELL Ready progressive multifocal IOL, the AT Lisa trifocal, and the FineVision trifocal lenses. The optical quality for each IOL was determined using an instrument for measuring real-time modulation transfer function, with a 3 mm and a 4.5 mm aperture. While 3 main peaks were found for each of the trifocal lenses using focus graphs, with the progressive multifocal Mini WELL Ready lens there were just 2 main areas. These included one for distance vision and another for intermediate and near acuity. When it came to the highest defocus tolerance, it was the Mini WELL Ready lens that fared the best, with deterioration of less than 15% detected for both apertures. Investigators concluded that after cataract surgery or refractive lens exchange, the Mini WELL Ready IOL was a good alternative to trifocal lenses. December 2015 Young Eye Surgeons (YES) Advanced Cataract Training Program launches in New York by Lisa Marie Romano ASCRS•ASOA Marketing Manager ASCRS update continued on page 12 Eric Donnenfeld, MD Jack Dodick, MD Elizabeth Yeu, MD Lisa Park, MD

Articles in this issue

Archives of this issue

view archives of Eyeworld - DEC 2015